Four women presented with symptomatic hypercalcaemia and raised concentrations of serum parathyroid hormone (PTH). In each case, serum calcium returned spontaneously to normal. In two patients serum PTH also fell to the normal range and biochemical relapse has not occurred despite prolonged follow-up. In the others, serum PTH remained elevated and subsequent symptomatic hypercalcaemia necessitated parathyroidectomy. In the first two cases, autoparathyroidectomy is the most likely explanation; the initial fall in serum calcium in the other two patients is unexplained. Large fluctuations in serum calcium may occur in some patients with hyperparathyroidism and prolonged and careful observation is required when this occurs.
Introduction
Hyperparathyroidism is characterized by hypercalcaemia in association with elevated levels of serum parathyroid hormone (PTH).' Minor fluctuations in serum calcium may occur in this condition. However, we report four patients with significant hypercalcaemia (serum calcium> 2.97 mmol/1) and elevated PTH concentrations, in whom serum calcium returned to normal without specific treatment.
Case reports
Case I An 82 year old woman presented with a 3-week history of confusion, constipation and nausea. She became immobile 2 days before hospital admission. There was no history of self-medication with vitamin D or antacids and no significant past medical history. On examination, she was found to be dehydrated and drowsy with corneal calcification. Plasma concentrations were as follows: urea 11.6 mmol/l (normal 2.5-6.5), creatinine 192 pmol/l (60-120), sodium 145 mmol/l (136-48), chloride99mmol/l (95-105), potassium 3.9 mmol/l (3.7-5.4), total CO2 24 mmol/l (22) (23) (24) (25) (26) (27) , free thyroxinel9pmol/l (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) , inorganic phosphate 0.85 mmol/l (0.8-1.4), alkaline phosphatase83IU/l (21-92) and serum calcium was > 4.01 mmol/l (2.1-2.6) on three occasions with serum albumin 44 g/l. The haemoglobin concentration was 16.9 g/dl (12-16), the appearance of the blood film was normal and the erythrocyte sedimentation rate (ESR) was 4mm/hour. Skeletal survey and technetium-99 bone scan showed no evidence of bone disease and a chest X-ray was normal.
She was treated with intravenous 0.9% saline, frusemide and oral prednisolone (40mg/day). Over the next few days, her condition improved markedly and serum calcium gradually returned to the normal range. However, PITH estimation on blood taken at the time of admission was subsequently found to be 470pg/ml (normal range <120, N-terminal assay) indicating hyperparathyroidism. Convalescence was complicated by an attack of acute pancreatitis and she was discharged from hospital 8 weeks after admission. Serum calcium remained within the normal range despite withdrawal of prednisolone 3 mmol/l, potassium 4.9 mmol/l, total CO2 25 mmol/l, inorganic phosphate 1.11 mmol/l, serum albumin 44 g/l, and serum PTH was 300 pg/ml (normal range <120, N-terminal assay). Haemoglobin concentration was 12.3 g/dl, ESR 10 mm/hour and serum immunogloblin concentrations normal. X-rays of the chest and hands and a skeletal survey showed no abnormality. She has been followed up for 2 years and serum calcium has remained normal. Serum PTH has now fallen to <40 pg/ml on two occasions.
Case 3
A 72 year old woman presented to her family practitioner with a 6-month history of weight loss, constipation, polyuria, polydipsia and lethargy. She was taking no medication and past medical history was unremarkable. There were no significant findings on examination but serum calcium was 4.01 mmol/l. She was referred to the medical outpatient department where hypercalcaemia was confirmed (4.02 mmol/1) and further investigation revealed that the plasma urea was 4.9 mmol/l, creatinine 69 gmol/l, sodium 144 mmol/l, potassium 4.3 mmol/l, total CO2 25 mmol/l, inorganic phosphate 0.56 mmol/l, serum albumin 45 g/l and alkaline phosphatase 1080 IU/l. Haemoglobin concentration was 15.3 g/dl, ESR 29 mm/hour and a discrete band was noted in the gamma region on serum electrophoresis; serum immunoglobulin concentrations, however, were normal. X-rays of the pelvis, spine, skull and femora were normal but X-ray of the hands revealed subperiosteal resorption of bone.
On review 4 A 72 year old woman was admitted with a 6-week history of lethargy, weakness and weight loss. She had suffered from asthma for many years (controlled by inhaled steroids and bronchodilators and oral prednisolone) and was also taking thyroxine 150 pg/day following radio-iodine treatment 30 years previously for thyrotoxicosis.
Mild hypercalcaemia (serum calcium 2.7mmol/1) had been discovered by routine biochemical analysis 13 years previously and this persisted for the next 10 years. On two occasions serum PTH concentration was estimated and found to be greater than 0.76 ng/ml (normal range < 0.2 C-terminal assay). No radiological features of hyperparathyroidism were present. During the 3 years prior to admission, the patient's serum calcium had fallen to 2.42 mmol/l but the serum PTH concentration was consistently elevated, varying between 0.8 and 1.3 ng/ml.
Examination revealed rhonchi on auscultation of the chest and proximal muscle weakness. Serum calcium concentration was again elevated at 2.97 mmol/l and serum PTH was 1.2 ng/ml. Plasma urea was 6 mmol/l, creatinine 99 gimol/l, sodium 141 mmol/l, potassium 4.4 mmol/l, serum albumin 42g/l, alkaline phosphatase 174U/l (70-350), haemoglobin 11.5 g/dl and ESR 5 mm/h. At surgical exploration of the neck, a large (1.5cm diameter) adenoma was removed from the right upper pole ofthe thyroid gland. Histological examination confirmed that this was an adenoma of the parathyroid. Transient hypocalcaemia developed post-operatively and the patient remains well and normocalcaemic 2 years later.
Discussion
All our patients were females aged over 55 years and, they presented with symptoms directly attributable to hypercalcaemia which resolved when serum calcium concentrations returned to the normal range. In all four, hypercalcaemia was accompanied by significant elevation of serum PTH concentration suggesting hyperparathyroidism.' The remarkable feature is that in each case, serum calcium returned to the normal range without specific treatment.
Two different biochemical patterns were observed. In the first two cases, serum PTH and calcium concentrations fell to the normal range at about the same time suggesting spontaneous remission of hyperparathyroidism. In the third and fourth cases, however, PTH levels remained elevated in spite of a fall in serum calcium to normal and subsequent relapse of hypercalcaemia necessitated parathyroidectomy in both instances.
A number ofexplanations might be offered for these observations. Firstly, there may have been another cause for hypercalcaemia but careful investigation in each case failed to confirm this possibility. The other main cause of hypercalcaemia, non-parathyroid malignancy,2 is very unlikely as the patients all remain well after follow-up periods of 18 months to 4 years. The high plasma phosphorus with normal renal function in case 2 would be unusual in hyperparathyroidism but PTH concentration was considerably elevated and alternative diagnoses seem improbable.
Assuming An alternative suggestion is that two patients (cases 1 and 2) underwent 'autoparathyroidectomy'. This is extremely rare but has been described in one patient with a parathyroid carcinoma' and another with a parathyroid adenoma8 and may be due to the tumour outstripping its blood supply. Another possibility is that, in rare instances, the parathyroid may become temporarily overactive causing a 'parathyroid storm', a situation analagous to the hyperthyroidism accompanying thyroiditis.
The situation is further complicated by the fact that in cases 2, 3 and 4, serum calcium concentrations returned to normal at a time when PTH concentrations were still elevated. This might be explained by secretion of an immunologically reactive PTH molecule with decreased biochemical potency or alteration in hormone receptor number or availability. This disparity has been observed in pseudohypoparathyroidism and in vitamin D deficiency where immunoreactive PTH can remain elevated in the presence of normal levels of bioactive PTH and normocalcaemia9 and familial hypocalciuric hypercalcaemia where bioactive PTH is in the normal range and immunoreactive PTH may be undetectable.'0 However, such an explanation would require sudden switching of PTH production to a form with low biological potency and this seems unlikely to occur.
These cases demonstrate that serum calcium in some patients with hyperparathyroidism may show marked fluctuation from toxic levels to the normal range. Unexpected and dramatic biochemical relapse may occur so that prolonged and careful review is necessary. We suggest that all patients with fluctuating hypercalcaemia are followed up at regular intervals until the pathogenesis and course becomes clearer.
